Pain and symptom relief using inhaled methoxyflurane for gynecologic brachytherapy applicator removal

Purpose: Intra-cavitary brachytherapy forms an essential part of the curative treatment of cervical and vaginal can-cer, and can be used for cure or palliation in endometrial and vulval cancers. Removal of brachytherapy applicators is often performed after anaesthesia has worn off and can be an uncomfortable and anxiety-provoking procedure. In this paper, we present our experience in a series of patients before and after the introduction of inhaled methoxyflurane (IMF, PenthroxTM).Material and methods: Questionnaires were sent to patients prior to the introduction of IMF to retrospectively score pain and anxiety during the brachytherapy procedure. Following successful review by the local drugs and ther-apeutic committee as well as staff training, IMF was introduced and offered to patients during applicator removal. Prospective pain scores and retrospective questionnaires were collected. Pain was rated on a scale of 0 to 10, with zero being no pain and 10 being extreme pain.Results: Thirteen patients returned retrospective questionnaires prior to IMF introduction and seven patients fol-lowing IMF introduction. After the first brachytherapy insertion, the mean recollected pain score during applicator removal decreased from 6/10 to 1/10 (p = 0.002). The mean recollected pain score one hour after applicator removal reduced from 3/10 to 0 (p = 0.04). Prospective measurements for 77 insertions in 44 patients receiving IMF reported a median pain score of 1/10 immediately before applicator removal (range, 0-10), and 0/10 immediately after applica-tor removal (range, 0-5).Conclusions: Inhaled methoxyflurane is easily administered and effective method of decreasing pain during appli- cator removal following gynecologic brachytherapy.